Open AccessRole of dexamethasone on oxygen requirement, mortality, and survival incidence among COVID-19 patients: Quasi-experimental study
Author(s) -
Lakshmi Mahajan,
Arvinder Singh,
Akshita Singla,
G. Singh
Publication year - 2021
Publication title -
al-banǧ. maqālāt wa abḥāṯ fī al-taẖdīr wa-al-in’āš
Language(s) - English
Resource type - Journals
ISSN - 0259-1162
DOI - 10.4103/aer.aer_70_21
Subject(s) - medicine , intensive care unit , mechanical ventilation , pneumonia , incidence (geometry) , randomized controlled trial , dexamethasone , group b , clinical trial , covid-19 , mortality rate , oxygen therapy , disease , infectious disease (medical specialty) , physics , optics
Patients diagnosed with coronavirus disease 2019 (COVID-19) are often prone to developing systemic inflammation which eventually causes damage to the lungs and other important organs. Randomized open-label control trials carried out in the different parts of the world have highlighted the importance of corticosteroids for treating such patients.